Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Work In Process (2018 - 2019)

Niagen Bioscience (NAGE) has disclosed Work In Process for 2 consecutive years, with $4.7 million as the latest value for Q4 2019.

  • Quarterly Work In Process rose 66.75% to $4.7 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2019, up 66.75% year-over-year, with the annual reading at $4.7 million for FY2019, 66.75% up from the prior year.
  • Work In Process for Q4 2019 was $4.7 million at Niagen Bioscience, up from $2.8 million in the prior quarter.
  • The five-year high for Work In Process was $4.7 million in Q4 2019, with the low at $2.8 million in Q4 2018.